 -To test the hypothesis that higher initial dose of basal insulin 0.3 Ukg is non inferior to standard initial dose 0.2 Ukg based on the percentage of patients with at least one episode of hypoglycemia 3.9 mmolL or severe during the 16 weeks of treatment in overweight and obese type 2 diabetic patients uncontrolled with oral anti-diabetes drugs OADs. 